HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
